Verition Fund Management
WST icon

Verition Fund Management’s West Pharmaceutical WST Stock Holding History

Verition Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.72M Buy
+21,511
New +$6.58M 0.04% 462
2026
Q1 		– Sell
-26,928
Closed -$7.41M – 3656
2025
Q4 		$7.41M Buy
26,928
+138
+0.5% +$37.7K 0.03% 613
2025
Q3 		$7.03M Buy
26,790
+22,614
+542% +$5.5M 0.03% 805
2025
Q2 		$914K Sell
4,176
-2,206
-35% -$472K ﹤0.01% 2546
2025
Q1 		$1.43M Buy
6,382
+4,883
+326% +$1.35M 0.01% 1830
2024
Q4 		$491K Sell
1,499
-3,669
-71% -$1.15M ﹤0.01% 2499
2024
Q3 		$1.55M Buy
5,168
+4,066
+369% +$1.25M 0.01% 1584
2024
Q2 		$363K Sell
1,102
-231
-17% -$81.6K ﹤0.01% 2239
2024
Q1 		$527K Sell
1,333
-886
-40% -$328K ﹤0.01% 1977
2023
Q4 		$781K Buy
2,219
+1,595
+256% +$564K 0.01% 1291
2023
Q3 		$234K Sell
624
-660
-51% -$255K ﹤0.01% 1886
2023
Q2 		$491K Buy
1,284
+629
+96% +$225K 0.01% 1250
2023
Q1 		$227K Buy
+655
New +$191K ﹤0.01% 1688
2022
Q4 		– Sell
-6,230
Closed -$1.53M – 2822
2022
Q3 		$1.53M Buy
6,230
+4,167
+202% +$1.27M 0.02% 1093
2022
Q2 		$624K Buy
+2,063
New +$671K 0.01% 1303
2019
Q4 		– Sell
-7,146
Closed -$1.01M – 1398
2019
Q3 		$1.01M Buy
+7,146
New +$984K 0.03% 412
2019
Q1 		– Sell
-2,075
Closed -$203K – 1342
2018
Q4 		$203K Sell
2,075
-9,568
-82% -$1.04M 0.01% 735
2018
Q3 		$1.44M Buy
+11,643
New +$1.31M 0.05% 427
2018
Q2 		– Sell
-6,549
Closed -$578K – 1357
2018
Q1 		$578K Buy
6,549
+2,413
+58% +$226K 0.04% 581
2017
Q4 		$408K Buy
+4,136
New +$406K 0.04% 558
2017
Q3 		– Sell
-8,051
Closed -$761K – 1404
2017
Q2 		$761K Buy
8,051
+3,195
+66% +$294K 0.07% 266
2017
Q1 		$396K Buy
+4,856
New +$406K 0.04% 701
2016
Q3 		– Sell
-5,942
Closed -$451K – 1327
2016
Q2 		$451K Buy
+5,942
New +$432K 0.06% 426

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Verition Fund Management's WST Position: Q2 2026 in Review

Verition Fund Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 21,511 shares worth $7.72M. The stake represents 0.04% of the portfolio and ranks #462 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in WST as recently as Q4 2025.

Verition Fund Management first reported a position in WST in Q2 2016 and has held it in 23 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Verition Fund Management held 21,511 shares of West Pharmaceutical worth $7.72M as of Q2 2026.
  • West Pharmaceutical was a new Verition Fund Management position in Q2 2026.
  • West Pharmaceutical made up 0.04% of Verition Fund Management's portfolio in Q2 2026, its #462 holding.
  • Verition Fund Management first reported a position in West Pharmaceutical in Q2 2016 and has held it in 23 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.